Peptide library · 53 records · 33 full reviews
Search by name. Full reviews explain the studies, results, and limits. Short records link to one source while a full review is pending. Open the filters only if you need them.
Showing 53 peptides of 53 · 53 records · 33 full reviews
Start with the name. Use a filter only when you need it. These records describe the evidence found in the review. They do not recommend treatment.
This review covers Ozempic, Rybelsus, Wegovy, and the Wegovy HD strength. Their forms, approved uses, and labels differ.
Approved medicine · Last checked 2026-08-30
Insulin is a family of diabetes medicines. Different products can have different timing, risks, and instructions.
Approved medicine · Last checked 2026-08-30
Some FDA-approved tirzepatide products have evidence for blood-sugar, weight, sleep-apnea, or heart-risk outcomes in specific groups of people. Each product's current label sets its uses and safety information.
Approved medicine · Last checked 2026-08-30
Cell and animal studies, plus small early studies in people, do not prove that BPC-157 heals injuries in people.
Research in progress · Last checked 2026-08-01
Short studies in healthy adults found that CJC-1295 raised growth hormone (GH) and insulin-like growth factor 1 (IGF-1). These hormone measurements do not prove better recovery, muscle gain, or fat loss.
Research in progress · Last checked 2026-08-02
A short human study measured growth-hormone release, but it did not prove health benefits. A different phase 2 study did not show benefit on its main or other measured outcomes.
Research in progress · Last checked 2026-07-23
An established prescription medicine. Its evidence applies to specific products, uses, groups of people, and current labels.
Approved medicine · Last checked 2026-07-23
Still being studied. Late-stage study reports show meaningful results in people, but no product is approved and no regulatory review is complete.
Research in progress · Last checked 2026-08-01
An investigational peptide made to act like the body's amylin signal. Human weight-loss studies exist, but no FDA-approved product exists.
Research in progress · Last checked 2026-08-30
SS-31 is elamipretide. FDA approved Forzinity for one narrow use, not for anti-aging.
Approved medicine · Last checked 2026-08-30
An Austrian-authorized finished product made from a pig-brain peptide mixture, not one peptide. Human trials exist, but no FDA-approved U.S. product was identified.
Research in progress · Last checked 2026-08-30
A research peptide that changed reproductive hormones for short periods in small human studies. This does not prove fertility, testosterone, or other treatment benefits.
Research in progress · Last checked 2026-08-30
A 28-amino-acid peptide studied in people. A large sepsis trial did not show fewer deaths, and no FDA-approved U.S. product was identified.
Research in progress · Last checked 2026-08-30
An approved medicine for one specific HIV-related body-composition outcome. It is not a general weight-loss or anti-aging medicine.
Approved medicine · Last checked 2026-08-01
Studies in people show a growth-hormone response. They do not prove broad anti-aging or muscle-building benefits. Former Geref products are no longer sold.
Research in progress · Last checked 2026-07-23
FDA-approved human products are discontinued. Animal products are not approved for people.
Past human approval; current animal products · Last checked 2026-08-30
A six-amino-acid research peptide. Small human studies show short-term growth-hormone changes, not proven muscle, fat-loss, or other lasting health benefits.
Research in progress · Last checked 2026-08-30
A seven-amino-acid piece of thymosin beta-4 promoted for repair, without reliable human healing evidence and with major product and anti-doping limits.
Unapproved or compounded · Last checked 2026-08-01
A three-amino-acid copper complex with topical and laboratory research. That research does not validate injectable, whole-body, or longevity claims.
Several or unclear types · Last checked 2026-07-23
A peptide first studied in cells and animals. It has no established outcomes from giving a MOTS-c drug product to people or adequate clinical safety record.
Unapproved or compounded · Last checked 2026-07-23
A modified piece of growth hormone studied in obesity programs. It has no approved use and unresolved route, product, and safety questions.
Research in progress · Last checked 2026-07-23
A four-amino-acid peptide promoted for sleep and longevity. Its evidence has identity-transfer problems and no established insomnia or lifespan outcome evidence.
Unapproved or compounded · Last checked 2026-07-23
An approved medicine for one defined sexual-desire disorder. It is not a general sexual-performance enhancer.
Approved medicine · Last checked 2026-08-01
An approved implant that increases pain-free light exposure in adults with EPP. It is not a general tanning or cosmetic peptide.
Approved medicine · Last checked 2026-07-23
An established osteoporosis medicine that can reduce fracture risk in defined groups. Its evidence does not apply to every fracture-healing claim.
Approved medicine · Last checked 2026-07-23
An approved osteoporosis medicine with fracture evidence in defined groups and product-specific safety limits.
Approved medicine · Last checked 2026-07-23
An established medicine that can reduce support given through a vein in short bowel syndrome. It needs intensive product-specific monitoring.
Approved medicine · Last checked 2026-07-23
An unapproved tanning peptide. Two small older studies measured pigment and erectile effects, while serious harms appear in case reports and the supply chain is unverified.
Research in progress · Last checked 2026-07-31
Semax is a seven-amino-acid peptide. FDA has not approved it. Human studies do not prove a benefit.
Research in progress · Last checked 2026-08-30
Selank is a seven-amino-acid peptide. Small studies in people do not prove that it treats anxiety or improves focus.
Research in progress · Last checked 2026-08-30
DSIP is a nine-amino-acid peptide. Studies do not prove it works. FDA has not approved DSIP.
Research in progress · Last checked 2026-08-30
LL-37 is a body-made peptide with 37 amino acids. Human studies do not prove a general health benefit. No FDA-approved LL-37 drug was found.
Research in progress · Last checked 2026-08-30
P21 peptide is also called P021 or P-21. Its benefits and safety in people are not known.
Unapproved or compounded · Last checked 2026-08-30
A U.S. Food and Drug Administration (FDA) product record exists for SANDOSTATIN. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for SOMATULINE DEPOT. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for SIGNIFOR. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for VASOSTRICT. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for TERLIVAZ. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for LUPRON DEPOT. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for ZOLADEX. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for CETROTIDE. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for GANIRELIX. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for FIRMAGON. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for SYMLIN. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for IMCIVREE. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for LINZESS. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for TRULANCE. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for PRIALT. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
A U.S. Food and Drug Administration (FDA) product record exists for ANGIOMAX. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
About these records
A name can be listed before its full review is ready. That record points to a specific source, but it does not tell you that a benefit or safety claim is proven. A full review is published after the main sources, important limits, review date, and each claim are checked.